Navidea biopharmaceuticals, inc. (NAVB)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue from contract with customer

15

3

5

16

14

36

22

264

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tc99m tilmanocept sales revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

8

17

4

8

-6,732

2,952

1,963

1,835

-

1,101

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lymphoseek sales revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,046

626

-

143

127

0

-

0

-

-

-

-

-

-

-

2,513

Tc99m tilmanocept license revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,295

245

254

250

550

250

83

0

300

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant and other revenue

141

116

231

244

38

84

209

277

275

386

223

511

580

1,022

510

916

685

540

476

654

189

-

848

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lymphoseek milestone revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Grant and other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28

125

-

256

67

0

-

0

60

-

-

-

-

335

-

-

License and grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

Revenues, Total

156

119

236

260

41

119

231

542

276

395

223

611

580

1,031

1,824

1,167

948

-5,942

3,979

2,867

2,108

-2,022

2,250

1,074

751

534

400

195

0

6

0

60

11

-

255

6

-

149

2,538

Cost of revenue

0

0

0

0

6

22

38

35

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

57

2

0

1

-1,236

457

332

449

-1,268

807

270

193

151

75

105

0

-

0

-

-

-

-

-

-

-

811

Gross profit

155

119

236

259

35

96

193

506

276

391

223

611

580

974

1,821

1,166

946

-4,706

3,521

2,535

1,659

-753

1,442

804

558

383

324

89

0

-

0

60

-

-

-

-

-

-

1,727

Operating expenses:
Research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,158

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,646

4,907

3,910

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

999

1,725

1,801

1,070

740

854

1,225

1,142

998

1,748

874

1,185

705

2,127

919

2,019

2,072

382

3,902

2,297

3,981

-

-

5,112

5,226

-

6,278

4,376

3,639

4,343

6,127

2,476

3,943

6,994

3,858

1,866

2,435

2,480

1,737

Selling, general and administrative

1,827

1,165

1,519

1,861

1,728

1,443

2,688

1,789

1,776

2,163

1,734

4,249

3,022

2,087

1,811

1,387

2,633

-2,597

3,942

4,048

5,494

-

-

-

-

-

3,971

4,169

3,364

2,690

2,941

2,970

2,574

2,048

2,870

1,727

2,901

1,287

918

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,646

4,907

3,910

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

2,827

2,891

3,321

2,932

2,469

2,298

3,914

2,932

2,775

3,911

2,609

5,435

3,727

4,214

2,731

3,407

4,705

-2,215

7,844

6,345

9,475

-1,319

6,804

10,019

9,137

13,435

10,249

8,546

7,004

7,033

9,069

5,446

6,518

9,042

6,728

3,593

5,337

3,768

2,655

Loss from operations

-2,671

-2,772

-3,084

-2,672

-2,433

-2,201

-3,721

-2,425

-2,499

-3,519

-2,385

-4,823

-3,147

-3,239

-909

-2,240

-3,758

-2,490

-4,323

-3,810

-7,816

565

-5,362

-9,215

-8,579

-13,052

-9,924

-8,456

-7,004

-7,026

-9,069

-5,386

-6,506

-9,042

-6,473

-3,587

-5,001

-3,618

-928

Other income (expense):
Interest income, net

-

-

-

-

-

-

-

-

31

24

76

44

24

-2

0

-2

0

3,420

-2,148

-1,575

-966

-599

-918

-909

-937

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest (expense) income, net

-2

1

11

1

9

-

-28

-23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

1

1

2

4

8

9

11

7

2

3

2

1

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

976

465

363

235

315

321

293

10

0

1

1

0

268

Equity in loss of R-NAV, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-2

-12

-10

-26

-6

-262

-261

-262

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of investment in R-NAV, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-39

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

-

-

-

0

0

12

140

1,102

-839

1,469

1,125

1,088

-1,577

-1,852

1,727

-1,232

-409

-92

392

265

-377

0

0

-

283

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

-

-

-

0

0

12

140

-

-839

1,469

-

-

-

-

-

-1,232

-409

-92

392

-

-377

0

0

-

283

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-1,026

0

0

-4,265

-2,887

0

0

-1,314

0

0

0

0

-

-

-2,440

-

0

0

0

-2,610

0

0

-1,372

0

-

0

-

-

-

-

-

-

-

-41,717

Change in derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-92

-184

-

7

-10

-953

-87

-154

Other, net

0

-1

-1

-3

-1

-0

3

2

-4

11

-6

-16

-21

21

-12

-0

-37

0

4

-4

26

31

53

-5

-6

0

-33

-8

24

0

-2

-41

-14

-1

-0

-0

-0

-0

-2

Total other income (expense), net

-2

0

10

-1

8

-1,037

-24

-20

-4,238

-2,851

69

40

-1,171

1,121

-851

1,424

1,076

4,499

-3,748

-5,880

524

-2,062

-1,536

-1,006

-3,161

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-2,673

-2,771

-3,074

-2,673

-2,424

-3,238

-3,745

-2,446

-6,737

-6,371

-2,316

-4,783

-4,318

-2,118

-1,761

-816

-2,681

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,037

-6,459

-3,596

-5,953

-3,704

-

Provision for income taxes

-

0

-0

-0

0

-

76

-10

-

-201

-775

-1,631

-1,454

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-476

-6,403

-478

-520

-

-

Net loss from continuing operations

-2,673

-2,771

-3,074

-2,673

-2,425

-3,163

-3,821

-2,435

-6,737

-6,170

-1,540

-3,151

-2,864

-2,118

-1,761

-816

-2,681

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations, net of tax effect:
Loss from discontinued operations, net of tax effect

-

0

0

0

-3

-

-

-1

-

-157

5

-82

-255

-

1,701

-5,864

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,004

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,610

-220

928

1,010

1,323

-0

Gain on sale of discontinued operations, net of tax effect

-

-

-

-

-

-

-

43

-

2,269

145

-1,953

88,701

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,108

-

-

-

-

Net loss

-2,673

-2,771

-3,074

-2,673

-2,429

-3,160

-3,821

-2,394

-6,737

-4,058

-1,389

-5,187

85,581

-

-59

-6,681

-

-2,510

-8,071

-9,690

-7,291

-

-6,898

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (loss) attributable to noncontrolling interest

0

0

-0

-0

-0

-0

-0

-0

-0

-0

-0

0

-0

-0

-0

-0

-0

-0

-0

-0

-0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-59

-6,681

-3,686

-

-

-

-

-

-

-10,222

-11,740

-

-

-

-

-

-9,098

-5,834

-6,989

-7,607

19,831

-2,188

-4,422

-2,381

-43,069

Deemed dividend on beneficial conversion feature of MT Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend on beneficial conversion feature of MT Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,381

-1,843

-336

-208

-29

-447

-482

4

13

-8

-952

-86

-42,140

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,560

-55

-3,117

-5,433

-3,704

-43,069

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-31

25

25

25

25

25

25

25

25

8,096

Net loss attributable to common stockholders

-2,673

-2,771

-3,074

-2,673

-2,429

-3,160

-3,821

-2,394

-6,737

-4,058

-1,389

-5,187

85,581

-

-

-

-3,686

-2,510

-8,070

-9,690

-7,337

-6,864

-6,898

-10,222

-11,740

-13,751

-11,306

-10,300

-7,341

-7,203

-9,123

-5,859

-7,014

-7,632

19,806

-2,213

-4,447

-2,406

-51,166

Continuing operations (in dollars per share)

-

-

-0.17

-0.24

-

-

-0.46

-0.30

-0.83

-0.03

-0.01

-0.02

-0.02

-0.01

-0.01

-0.01

-0.02

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

0.01

0.00

-0.01

0.55

-0.02

0.01

-0.03

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Attributable to common stockholders (in dollars per share)

-

-

-

-

-

-

-

-

-0.83

-0.02

-0.01

-0.03

0.53

-0.03

0.00

-0.04

-0.02

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding (in shares)

-

-

-

-

-

-

-

-

8,113

162,076

162,006

161,910

160,376

155,517

155,481

155,382

155,308

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-0.03

-0.01

-0.02

-0.02

-0.01

-0.01

-0.01

-0.02

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations (in dollars per share)

-

-

-

-

-

-

-

-

-

0.00

0.00

-0.01

0.54

-0.02

0.01

-0.03

0.00

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Attributable to common stockholders (in dollars per share)

-

-

-

-

-

-

-

-

-

-0.03

-0.01

-0.03

0.52

-0.03

0.00

-0.04

-0.02

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding (diluted) (in shares)

-

-

-

-

-

-

-

-

-

175,276

162,006

161,910

164,871

155,517

155,481

155,382

155,308

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss per common share (basic and diluted):
Continuing operations (in dollars per share)

-0.13

-

-

-

-0.24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.08

0.00

-0.03

-0.06

-0.05

-0.64

Discontinued operations (in dollars per share)

-

-

-

-

-

-

-

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.21

0.01

0.01

0.02

0.00

Attributable to common stockholders (in dollars per share)

-0.13

-0.11

-0.17

-0.24

-0.24

-

-0.46

-0.29

-

-

-

-

-

-

-

-

-

-

-0.05

-0.06

-0.05

-0.04

-0.05

-0.07

-0.08

-0.11

-0.09

-0.09

-0.06

-0.07

-0.09

-0.06

-0.07

-0.08

0.21

-0.02

-0.05

-0.03

-0.64

Weighted average shares outstanding (in shares)

20,203

18,414

18,044

11,096

10,017

-

8,342

8,135

-

-

-

-

-

-

-

-

-

-

150,186

150,107

149,794

150,020

150,169

150,019

144,783

134,094

121,117

118,260

113,763

105,167

102,332

94,664

94,074

-

93,070

89,660

-

-

-

Basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

85,416

80,605

80,260

Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-59

-6,681

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,381

-43,069

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

8,096

Royalty [Member]
Revenue from contract with customer

15

2

4

5

3

5

2

6

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License [Member]
Revenue from contract with customer

-

-

-

9

-

-

19

257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-